Novel drugs that target the metabolic reprogramming in renal cell cancer
Crossref DOI link: https://doi.org/10.1186/s40170-016-0154-8
Published Online: 2016-07-13
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van der Mijn, Johannes C.
Panka, David J.
Geissler, Andrew K.
Verheul, Henk. M.
Mier, James W.